This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Possible Implication for Other Screening Procedures for Newborns

Vanja A. Holm, MD; William M. Deering, MD; Rhesa L. Penn, MD, MPH

JAMA. 1970;212(11):1835-1842.

Abstract
Mandatory legislation for phenylketonuria (PKU) screening has recently created considerable controversy. This report analyzes three years' experience with a voluntary program in the state of Washington. Sixty-nine percent of newborns were screened in 1967, the last year of the survey reported. The major factor influencing development of screening practice seemed to be physician interrelationships, strongest in the most populous communities, which either favored or hindered the adoption of a screening program. Other medicosociological factors considered had less or no influence. Further observations made that might be considered when planning future mass screening programs were (1) sparsely populated areas and small hospitals need support; (2) the type of testing policy adopted by a hospital staff determines the effectiveness of its program; and (3) screening programs need periodic surveillance to continue to be effective.

Author Affiliations
From the Department of Pediatrics, University of Washington School of Medicine, Seattle, and Washington State Department of Health (Dr. Penn), Olympia, Wash. Dr. Deering is now at Bernadillo County Medical Center, Albuquerque, NM. Dr. Penn is now with the University of Washington School of Medicine.

Footnotes
Reprint requests to Clinical Training Unit, Child Development and Mental Retardation Center, University of Washington, Seattle 98105 (Dr. Holm).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?